Rasio rega marang prakiraan pendapatan Kiora Pharmaceuticals Inc. (KPRX)

Kiora Pharmaceuticals (KPRX) is attracting leading ophthalmologists to develop treatments for rare eye pathologies. The expected P/S dynamics on GURU.Markets confirm this status, with the parameter reaching 5.50. While the current revenue deficit and capital burn result in negative earnings, the strategy to scale retina testing is aimed at securing commercial B2B partnerships as quickly as possible.

KPRX Kiora Pharmaceuticals, Inc.: Rega forward marang dodolan ing interval 12.05.2024 - 14.11.2026

Rincian metrik komprehensif lan analitis kiorapharma.com (KPRX)

- rega saiki lan proyeksi nilai saham:

Rega saham Kiora Pharmaceuticals, Inc.|KPRX - Target median analis

- rincian kapitalisasi pasar:

Nilai pasar Kiora Pharmaceuticals|KPRX - Total Nilai Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Kiora Pharmaceuticals|KPRX - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku kiorapharma.com|KPRX - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Kiora Pharmaceuticals|KPRX - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Kiora Pharmaceuticals, Inc.|KPRX - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku Kiora Pharmaceuticals|KPRX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Kiora Pharmaceuticals|Likuiditas cepet kiorapharma.com

- data bathi bisnis lan rasio investasi:

KPRX - Bathi pungkasan|Bathi sing dikarepake Kiora Pharmaceuticals|KPRX - Koefisien rega marang bathi|Pangali Forward P/E Kiora Pharmaceuticals, Inc.|KPRX - Pangali PEG|Pangali EV/EBITDA Kiora Pharmaceuticals|KPRX - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Kiora Pharmaceuticals|KPRX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan kiorapharma.com|KPRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Kiora Pharmaceuticals

- statistik dodolan lan pendapatan perusahaan:

KPRX - Total dodolan perusahaan|Prakiraan volume dodolan Kiora Pharmaceuticals, Inc.|KPRX - Koefisien rega marang pendapatan|Multiplikator Forward P/S Kiora Pharmaceuticals

Pambiji fundamental:Kiora Pharma KPRX

Produk sing diprodhuksi Kiora Pharmaceuticals, Inc.

The forward P/S ratio compares the current market value of Kiora Pharmaceuticals (KPRX) with expected future sales volume, allowing for an assessment of capitalization efficiency relative to prospective cash flows. Analyzing the company's forward P/S helps determine the asset's margin of safety, which is particularly relevant for the non-cyclical ophthalmology sector, where business value depends on the success of clinical trials and patent protection rather than macroeconomics.

Pesaing wigati